Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
27.32 USD | +0.11% |
|
+5.08% | -35.15% |
03/06 | Oppenheimer Adjusts Immunovant Price Target to $46 From $50, Maintains Outperform Rating | MT |
30/05 | Sector Update: Health Care Stocks Mixed Pre-Bell Thursday | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-35.15% | 399.02Cr | |
+34.14% | 5.11TCr | |
-6.54% | 3.94TCr | |
+34.92% | 3.85TCr | |
-12.11% | 2.62TCr | |
+12.62% | 2.64TCr | |
-13.43% | 2.1TCr | |
+43.73% | 1.4TCr | |
+31.81% | 1.25TCr | |
-4.54% | 1.16TCr |
- Stock Market
- Equities
- IMVT Stock
- News Immunovant, Inc.
- Immunovant Insider Sold Shares Worth $479,233, According to a Recent SEC Filing